Beta-blockers (patient information)

Revision as of 22:52, 8 August 2012 by WikiBot (talk | contribs) (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Cardiology Network

Discuss Beta-blockers (patient information) further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]



Overview

These drugs are used in the treatment of heart disease patients to slow the heart rate down, and to reduce the risk of irregular or fast heart beats. They can also be used to reduce the blood pressure. One side effect is an increases risk of wheezing or a worsening of lung congestion due to heart failure.

Specific agents include:

Atenolol

Inderal

Lopressor

Propranolol


Template:WikiDoc Sources